Bilaketaren emaitzak - Ana da Costa Miranda

Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors... nork Maria Inês Teodoro, Alexandra Mayer, Ana da Costa Miranda, Hugo Nunes, Filipa Alves da Costa, António Lourenço

Connect to this object online.